Rheumatoid arthritis and the risk of cancer in the treatment with Abatacept

A new post-marketing world observation study

Researchers wanted to investigate whether abatacept in patients with RA has an increased risk of reporting overall cancer and certain cancers such as breast, lung, lymphoma, melanoma and non-melanoma skin cancer compared to other biological DMARDs (bDMARDs).

Clinical Trials
Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase